Synonyms: SB-207499
Compound class:
Synthetic organic
Comment: There is some ambiguity in the literature and on other database as to the exact structure of Cilomilast. The structure shown here matches that of the INN document, but the compound is represented on PubChem without specified stereochemistry by CID 151170.
|
|
No information available. |
Summary of Clinical Use ![]() |
Cilomilast is being investigated for the treatment of conditions such as chronic obstructive pulmonary disease (COPD), bronchopulmonary dysplasia and asthma. ClinicalTrials.gov lists one completed trial for this compound (NCT00103922) |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Cilomilast is a selective phosphodiesterase-4 (PDE4) inhibitor IC50 120nM [2]. This action is believed to confer the compound's anti-inflammatory activity. In vitro studies have shown that cilomilast suppresses LPS-induced TNF-α formation in isolated human monocytes (pIC50 7.0) and produces a modest inhibition of fMLP-induced degranulation of human neutrophils (pIC50 7.1) [1]. |